Valuing a reduction in the risk and severity of asthma: A large scale multi-country stated preference approach

Gildas Appéré, Damien Dussaux, Alan Krupnick and Muriel Travers ()
Additional contact information
Damien Dussaux: OCDE - Organisation de Coopération et de Développement Economiques = Organisation for Economic Co-operation and Development
Alan Krupnick: RESOURCES FOR THE FUTURE WASHINGTON DC USA - Partenaires IRSTEA - IRSTEA - Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture
Muriel Travers: Nantes Univ - Nantes Université

Post-Print from HAL

Abstract: Asthma is a non-communicable and non-curable lung disease that affects 10% of children and 4% of adults worldwide and is associated with an array of environmental contaminants and chemicals. This article offers values suitable for use in cost–benefit analyses of the willingness to pay (WTP) for reduced severity of asthma in adults and children and in reduced probability of getting asthma for these two population groups, all in the context of reducing chemical exposures. To this end, an online survey was administered between November 2021 and May 2022 to 12 727 respondents from seven countries of the Organisation for Economic Co-operation and Development (OECD). This article applies two stated preference methods for eliciting WTP: the contingent valuation method for reduced asthma severity and choice experiments for reduced probability of getting asthma of various severities. The context for such elicitations was a set of household products that contain fewer hazardous chemicals than what is currently available in supermarkets but are more expensive. The study finds that the WTP for reducing asthma severity in adults by one step, e.g. from "moderate plus" to "moderate", isUSD2022 529 per year on average. The parental WTP for reducing asthma severity in their children is USD2022 PPP 948 per year and is on average 1.8 times higher than their WTP for themselves. The mean value of a statistical case (VSC) of adult asthma which would be applied to predictions of new cases of asthma avoided by a regulation equals USD2022 280 000, while the mean VSC of childhood asthma equals USD2022 430 000.

Keywords: Asthma; Health risk; Economic valuation; Stated preferences; Value of a statistical case (search for similar items in EconPapers)
Date: 2024-04-26
New Economics Papers: this item is included in nep-dcm and nep-env
Note: View the original document on HAL open archive server: https://hal.science/hal-04436960v1
References: Add references at CitEc
Citations:

Published in Journal of Benefit-Cost Analysis, 2024, pp.1-73

Downloads: (external link)
https://hal.science/hal-04436960v1/document (application/pdf)

Related works:
Working Paper: Valuing a reduction in the risk and severity of asthma: A large scale multi-country stated reference approach (2024)
Working Paper: Valuing a reduction in the risk and severity of asthma: A large scale multi-country stated preference approach (2023)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-04436960

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().